FDA approves first CRISPR therapy—here's how it works against sickle cell - Ars Technica
arstechnica.comSubmitted by arstechnica3419 in business
The landmark treatment turns on another blood protein that prevents sickling.
Submitted by arstechnica3419 in business
The landmark treatment turns on another blood protein that prevents sickling.